The FDA is reviewing the first mRNA flu vaccine for adults 50 and older. Learn how this technology could lead to faster and ...

Overcoming efficacy, safety, and manufacturing hurdles through innovative personalized cancer vaccine design ...

Experts deliberate on navigating the future of biologics & mRNA at the Indian Pharmaceutical Alliance webinar: Our Bureau, Bengaluru Monday, March 30, 2026, 16:45 Hrs [IST] Biolog ...

The API CDMO market presents opportunities in outsourcing, flexible solutions, and strategic partnerships, driven by ...

Not all parts of our genetic code are equal, even when they appear to say the same thing. Scientists have discovered that ...

GenScript, founded in 2002 in New Jersey, has announced the official opening of its first European mRNA production site in Delft, the Netherlands, marking a significant expansion of the company's ...

How do cells ensure that the "blueprints" of genetic information-RNA are accurate and intact before they are exported from ...

Explore how parenteral manufacturing solutions are evolving for specific drug formulations and meeting the demands of advanced therapies.

"We're just scratching the surface in terms of what they covered up," Permanent Subcommittee on Investigations chair says.

Confirmed, pooled, blinded COVID-19 events in the ongoing Phase 3 DECLARATION study of VYD2311 accumulated to date (~ 50% of study progress) can ...